Company / PP&E per Share
Relay Therapeutics, Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.01 / $0.11
FY2021-FY2025
Trend
-77.8%
vs FY2024
Sector context
#159 of 191
Health Care
What the data says
Relay Therapeutics, Inc.'s pp&e per share of $0.01 is lower than 83% of companies in the Health Care sector (FY2025). PP&E per Share has declined for 3 consecutive years, from $0.11 in FY2022 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -63.3%.
Declined from $0.09 to $0.01 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -54.3%
- 5-Year CAGR
- -63.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 191This company $0.01 Sector average $18.90
▼
-99.9% below sector average
Key checks
Key Insights
- Relay Therapeutics, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 77.8% year-over-year.
- Ranks #159 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -77.8% |
| FY2024 | $0.05 | -48.5% |
| FY2023 | $0.09 | -16.3% |
| FY2022 | $0.11 | +47.7% |
| FY2021 | $0.07 | -95.3% |
| FY2020 | $1.55 | -34.0% |
| FY2019 | $2.35 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026